Literature DB >> 28843904

Regulation of epithelial cell expressed C3 in the intestine - Relevance for the pathophysiology of inflammatory bowel disease?

Annika Sünderhauf1, Kerstin Skibbe1, Sophie Preisker1, Karen Ebbert1, Admar Verschoor2, Christian M Karsten2, Claudia Kemper3, Markus Huber-Lang4, Marijana Basic5, André Bleich5, Jürgen Büning6, Klaus Fellermann6, Christian Sina7, Stefanie Derer8.   

Abstract

The complement system not only plays a critical role in efficient detection and clearance of bacteria, but also in intestinal immune homeostasis as mice deficient for key complement components display enhanced intestinal inflammation upon experimental colitis. Because underlying molecular mechanisms for this observation are unclear, we investigated the crosstalk between intestinal epithelial cells (IEC), bacteria and the complement system in the course of chronic colitis. Surprisingly, mouse intestinal epithelial cell lines constitutively express high mRNA levels of complement component 3 (C3), Toll-like receptor 2 (Tlr2) and Tlr4. Stimulation of these cells with lipopolysaccharide (LPS), but not with flagellin, LD-muramyldipeptide or peptidoglycan, triggered increased C3 expression, secretion and activation. Stimulation of the C3aR on these cell lines with C3a resulted in an increase of LPS-triggered pro-inflammatory response. Tissue biopsies from C57BL/6J mice revealed higher expression of C3, Tlr1, Tlr2 and Tlr4 in colonic primary IECs (pIECs) compared to ileal pIECs, while in germ-free mice no differences in C3 protein expression was observed. In DSS-induced chronic colitis mouse models, C3 mRNA expression was upregulated in colonic biopsies and ileal pIECs with elevated C3 protein in the lamina propria, IECs and the mucus. Notably, increased C3b opsonization of mucosa-attached bacteria and decreased fecal full-length C3 protein was observed in DSS-treated compared to untreated mice. Of significant interest, non-inflamed and inflamed colonic biopsy samples from CD but not UC patients displayed exacerbated C3 expression compared to controls. These findings suggest that a novel TLR4-C3 axis could control the intestinal immune response during chronic colitis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C3; Chronic colitis; Inflammatory bowel disease; Intestinal bacteria; Intestinal epithelial cells; LPS; Toll-like receptors

Mesh:

Substances:

Year:  2017        PMID: 28843904     DOI: 10.1016/j.molimm.2017.08.003

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  18 in total

1.  Back to the future - non-canonical functions of complement.

Authors:  Claudia Kemper; Jörg Köhl
Journal:  Semin Immunol       Date:  2018-06       Impact factor: 11.130

2.  Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death.

Authors:  Hrishikesh S Kulkarni; Michelle L Elvington; Yi-Chieh Perng; M Kathryn Liszewski; Derek E Byers; Christopher Farkouh; Roger D Yusen; Deborah J Lenschow; Steven L Brody; John P Atkinson
Journal:  Am J Respir Cell Mol Biol       Date:  2019-02       Impact factor: 6.914

3.  As in Real Estate, Location Matters: Cellular Expression of Complement Varies Between Macular and Peripheral Regions of the Retina and Supporting Tissues.

Authors:  Randy Zauhar; Josef Biber; Yassin Jabri; Mijin Kim; Jian Hu; Lew Kaplan; Anna M Pfaller; Nicole Schäfer; Volker Enzmann; Ursula Schlötzer-Schrehardt; Tobias Straub; Stefanie M Hauck; Paul D Gamlin; Michael B McFerrin; Jeffrey Messinger; Christianne E Strang; Christine A Curcio; Nicholas Dana; Diana Pauly; Antje Grosche; Mingyao Li; Dwight Stambolian
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

Review 4.  Emerging roles of the complement system in host-pathogen interactions.

Authors:  Sanjaya K Sahu; Devesha H Kulkarni; Ayse N Ozanturk; Lina Ma; Hrishikesh S Kulkarni
Journal:  Trends Microbiol       Date:  2021-09-29       Impact factor: 17.079

5.  Bacteriophages targeting intestinal epithelial cells: a potential novel form of immunotherapy.

Authors:  Andrzej Górski; Ewa Jończyk-Matysiak; Marzanna Łusiak-Szelachowska; Ryszard Międzybrodzki; Beata Weber-Dąbrowska; Jan Borysowski
Journal:  Cell Mol Life Sci       Date:  2017-11-21       Impact factor: 9.261

Review 6.  Challenge to the Intestinal Mucosa During Sepsis.

Authors:  Felix Haussner; Shinjini Chakraborty; Rebecca Halbgebauer; Markus Huber-Lang
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

7.  Saccharin Supplementation Inhibits Bacterial Growth and Reduces Experimental Colitis in Mice.

Authors:  Annika Sünderhauf; René Pagel; Axel Künstner; Anika E Wagner; Jan Rupp; Saleh M Ibrahim; Stefanie Derer; Christian Sina
Journal:  Nutrients       Date:  2020-04-17       Impact factor: 5.717

8.  C3a receptor antagonism as a novel therapeutic target for chronic rhinosinusitis.

Authors:  Jennifer K Mulligan; Kunal Patel; Tucker Williamson; Nicholas Reaves; William Carroll; Sarah E Stephenson; Peng Gao; Richard R Drake; Benjamin A Neely; Stephen Tomlinson; Rodney J Schlosser; Carl Atkinson
Journal:  Mucosal Immunol       Date:  2018-06-15       Impact factor: 7.313

9.  Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems.

Authors:  Mary Ajamian; David Steer; Gennaro Rosella; Peter R Gibson
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

10.  Crohn's Disease Patients in Remission Display an Enhanced Intestinal IgM⁺ B Cell Count in Concert with a Strong Activation of the Intestinal Complement System.

Authors:  Sophie Preisker; Ann-Kathrin Brethack; Arne Bokemeyer; Dominik Bettenworth; Christian Sina; Stefanie Derer
Journal:  Cells       Date:  2019-01-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.